Category: Cardiogenic Shock

Abiomed Cardiogenic Shock Protocol

The Impella 2.5®, Impella CP® and Impella 5.0®/ Impella LD® Heart Pumps and Impella RP® Heart Pump, in conjunction with the Automated Impella® Controller (AIC), are temporary ventricular support devices intended for short term use and indicated for the treatment of ongoing cardiogenic shock that occurs immediately following acute myocardial infarction or open heart surgery … Continue reading “Abiomed Cardiogenic Shock Protocol”

Cardiogenic Shock Clinical Dossier

Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now  FDA indicated to provide treatment of ongoing cardiogenic shock. In this setting, the Impella® heart pumps have the ability to stabilize the patient’s hemodynamics, unload the left ventricle, perfuse the end organs, and allow for recovery of the native heart.